Mediamedic/LinkedIn
Oct 4, 2025, 10:05
ISEH 2025 China–Japan Dialogue With Professors Jianxiang Wang and Naoki Hosen
Mediamedic shared a post on LinkedIn:
“ISEH 2025 China–Japan Dialogue | Professors Jianxiang Wang & Naoki Hosen: CAR-T Therapy for Leukemia and Global Collaboration
At the 54th ISEH Annual Scientific Meeting in Kumamoto, Japan, Professor Jianxiang Wang (Institute of Hematology & Blood Diseases Hospital, CAMS) and Professor Naoki Hosen (Osaka University) engaged in a deep dialogue on the future of CAR-T therapy for leukemia.
Their conversation explored basic mechanisms, clinical applications, efficacy optimization, and future directions, highlighting the importance of international collaboration to expand innovation and patient access worldwide.”
Stay updated with Hemostasis Today.
-
Feb 25, 2026, 15:06Nasrin Haghani: How Vitamin K2 Reduces Arterial Plaque Buildup and Promotes Heart Health
-
Feb 25, 2026, 14:33Ahmad Hazri Mohamed Aris: Drafting the 2026–2030 Indonesia PACT National Access Plan with IHS
-
Feb 25, 2026, 14:28Abdul Mannan: Preventing Transfusion Death Starts with Early Recognition of TACO
-
Feb 25, 2026, 14:23Obi Light Ogbonnia: The Power of Lived Experience in Health Policy and Research
-
Feb 25, 2026, 14:19Can Hormonal Birth Control Cause Blood Clots? – ASH
-
Feb 25, 2026, 14:13AbQader Bedil: 7 Urgent Red Flags in a Peripheral Blood Smear
-
Feb 25, 2026, 14:07Sumedha Dash: Why Whole Blood is Rarely the Answer Anymore?
-
Feb 25, 2026, 14:05Patient Perspectives on HMB in Women with Very Rare Bleeding Disorders – EAHAD
-
Feb 25, 2026, 13:36Zoltan Nagy: Antibody Response Can Shift from Recognizing the Adenoviral Protein to Targeting PF4 in Rare VITT Cases